InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JFM | jf meridian net profit up 11.8pc | 22/08/06 | 0 | 170 | |||
|
|||||||
JFM | $126.9 million capital raising | 03/02/05 | 0 | 237 | |||
|
|||||||
JFM | advice re trading halt | 03/02/05 | 0 | 134 | |||
|
|||||||
JFM | enters into mortgage/heads of agree.-acq new dev. | 01/02/05 | 0 | 206 | |||
|
See All Discussions